JELLINEK FRANK H JR 4
4 · FISHER SCIENTIFIC INTERNATIONAL INC · Filed Jul 5, 2005
Insider Transaction Report
Form 4
JELLINEK FRANK H JR
Director
Transactions
- Sale
Common Stock
2005-07-01$64.33/sh−15,000$964,999→ 72,132 total - Exercise/Conversion
Stock Options (Right to buy)
2005-07-01−15,000→ 228,172 totalExercise: $35.10From: 2004-08-02Exp: 2008-04-27→ Common Stock (15,000 underlying) - Sale
Common Stock
2005-07-01$64.35/sh−5,000$321,750→ 67,132 total - Exercise/Conversion
Common Stock
2005-07-01$35.10/sh+15,000$526,500→ 87,132 total
Holdings
- 850(indirect: by 401 (k))
Common Stock
Footnotes (3)
- [F1]The exercise and sale of the option shares and directly owned shares were accomplished pursuant to a 10b5-1(c) plan adopted on December 8, 2004.
- [F2]The sales price shown is the aggregate sales price for all option shares sold on July 1, 2005, actual sales denominations are as follows: 1,400 shares at $64.30; 1,000 shares at $64.31; 100 shares at $64.32; 6,600 shares at $64.33; 500 shares at $64.34; 5,400 shares at $64.35.
- [F3]The shares underlying the option became fully vested and exercisable upon the merger of Apogent Technologies Inc. with and into Fox Merger Corporation, a wholly owned subsidiary of Fisher Scientific International Inc., on August 2, 2004.